{"id":13457,"date":"2016-08-24T11:21:08","date_gmt":"2016-08-24T15:21:08","guid":{"rendered":"https:\/\/www.bu.edu\/urop\/?post_type=profile&#038;p=13457"},"modified":"2017-06-09T12:42:16","modified_gmt":"2017-06-09T16:42:16","slug":"reiko-matsui","status":"publish","type":"profile","link":"https:\/\/www.bu.edu\/urop\/profile\/reiko-matsui\/","title":{"rendered":"Reiko Matsui"},"content":{"rendered":"<p>Research expertise and personal interests: oxidants mediate cellular redox signaling through post-translational modification of protein thiols. My group studies the role of an enzyme glutaredoxin which controls S-glutathionylation (glutathione adducts) in cardiovascular disease, inflammation, and glucose metabolism.<\/p>\n<p>Recently I focus on angiogenesis and hypoxia-induced factor (HIF-1) regulation by glutaredoxin using mouse models. My goal is to develop our study into therapeutic strategy for clinical problems including diabetic ischemic limbs.<\/p>\n","protected":false},"author":11489,"template":"","_links":{"self":[{"href":"https:\/\/www.bu.edu\/urop\/wp-json\/wp\/v2\/profile\/13457"}],"collection":[{"href":"https:\/\/www.bu.edu\/urop\/wp-json\/wp\/v2\/profile"}],"about":[{"href":"https:\/\/www.bu.edu\/urop\/wp-json\/wp\/v2\/types\/profile"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/urop\/wp-json\/wp\/v2\/users\/11489"}],"version-history":[{"count":2,"href":"https:\/\/www.bu.edu\/urop\/wp-json\/wp\/v2\/profile\/13457\/revisions"}],"predecessor-version":[{"id":14247,"href":"https:\/\/www.bu.edu\/urop\/wp-json\/wp\/v2\/profile\/13457\/revisions\/14247"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/urop\/wp-json\/wp\/v2\/media?parent=13457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}